The trajectory of companies tied to Viagra's legacy presents a complex investment scenario . While the initial success generated substantial profits , generic copies have significantly impacted market share . Investing in related pharmaceutical firms now requires a careful assessment of patent rights , evolving healthcare trends , and the potential